| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
First Tracks Biotherapeutics, Inc. (TRAXV) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 1 sell. TRAXV is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.17M | $71.46M | -4,705,575 | |
| CEO | 379.6K | $8.55M | - | |
| Other | 83.5K | $1.88M | - | |
| CFO | 41.2K | $928.2K | - | |
| Dir | 28.6K | $643.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Ecor1 Capital, LLC77 | 10% Owner | Sell | 4,705,575 | $13.81 | $64,999,989.71 | -59.7% |